Open Call To Include New Beneficiaries Into The EUCAIM Consortium

Published on: April 19, 2024
Categories: News
The EUCAIM project is launching an open call for new beneficiaries to join the consortium. The objective of the EUCAIM open call is to:

i) onboard new cancer image data holders, increasing the geographic dimensions, data modalities or cancer targets, and 

ii) include new reliable AI algorithms trained on the cancer image data of the repository.

To reach the above objectives, the new beneficiaries will implement data incorporation, scientific and/or clinical use cases. A use case refers to a specific scenario or situation in which the Cancer Image Europe platform is used to address a real-life scientific or clinical question where access and re-use of large amounts of cancer data can improve patient outcomes.

The following use cases are accepted for this call:

  • Incorporation of large amounts of cancer imaging data into the Cancer Image Europe platform for further re-use, which can be leveraged to address relevant clinical questions (either into the central repository or through the federation of local repositories)
  • Development, training, benchmarking and/or validation of AI algorithms
  • Clinical use cases addressing a specific question (e.g. identification of imaging biomarkers)

The full call text can be found on the Cancer Image Europe website: cancerimage.eu/open-call.

Deadline for submission is 10 June 2024.

Applicants can contact opencall@cancerimage.eu for further details and assistance during the application process.

Application form

Webinar Alert: Learn More About EUCAIM’s Open Call For New Beneficiaries!

EUCAIM is excited to announce an upcoming webinar dedicated to providing more insights into our abovementioned open call for new beneficiaries. This webinar presents a unique opportunity for individuals and organisations interested in contributing to cutting-edge cancer research and innovation to learn about joining the EUCAIM consortium. The open call is geared towards incorporating new data into the EUCAIM platform and training, benchmarking, and validating AI algorithms for cancer imaging. During the webinar, participants will gain a comprehensive understanding of the open call process, including eligibility criteria, application requirements, application procedure, etc. Attendees will also have the opportunity to ask questions and interact with members of the EUCAIM team.

Don’t miss out on this valuable opportunity to learn more about the EUCAIM open call and how you can contribute to shaping the future of cancer imaging research. Mark your calendars and register now to secure your spot!

Date: April 26th, 2024.

Time: 10:00-11.30 AM CEST.

Location: Online webinar – Link will be sent to all registered participants in due course.

Webinar registration: https://form.jotform.com/240983490161054

 

Highlights

The brand effect: how different MRI machines trip up AI

The brand effect: how different MRI machines trip up AI

Prostate cancer can vary greatly in how aggressive it is, and knowing this in advance helps doctors decide the best course of treatment. Magnetic resonance imaging (MRI) is often used to detect prostate cancer, but figuring out just how aggressive the cancer is...

Dissemination Event of the ProCAncer-I Project in Vienna

Dissemination Event of the ProCAncer-I Project in Vienna

We are delighted to invite you to our session, “ProCAncer-I: An AI Platform Integrating Multiparametric MRI and AI Models”, at the European Congress of Radiology (ECR) 2025.  Date: 26 February 2025  Time: 15:00 – 16:00  Location: ECR 2025, Vienna, Austria (conference...

ProCAncer-I at the ECR 2025 in Vienna

ProCAncer-I at the ECR 2025 in Vienna

ProCAncer-I will organise a Dedicated Session on the project during the European Congress of Radiology 2025 on the 26th of February 2025, at 15.00-16.00, with the title "ProCAncer-I: an AI platform integrating multiparametric MRI and AI models" where we will present...

Stay in touch!